Implant Veterans of Toxic Exposure

American Medical Technology-1

Home
Action
Alerts
Hayes
Congressional Report
AMT-1
AMT Audit
Fly-In
ASPRS Survey
Bell & Pointer
BI Capsules
BI Chemicals
BI Numbers - Dow
Burson-Marsteller
B-M's Spokesdoctors
Dr. Pierre Blais
Burson - NEW
Cab-O-Sil
CANDO
Capsules
Chemical Adverse
ChemBMS
Children
Chem Soup
Connie Chung
CRS_safety
Dowknew1
Dowknew2
Dowknew3
Dowknew4
Dow Bleed
Dow Disease
Dow Fraud
Dow Migration
Dow Rupture
DC Whines
Dr. Anderson
Explant
Gagged
Gel Reaction
Griffin Bell
Hancock
Harvard-Brigham
HAD
Inflammation
Jenny
Judge Jones Transcript
Kessler
Latissimus
Maryland Informed
McKennon
McGhan-Shells
Poem to Congress
No Evidence
Cole
Norman Cole
Notable People
Scleroderma
SS
Study-Adjuvant
Study-Adjuvant-FDA
Study-Beagle
Study-Dogs
Study NY
Study-Tissue Reaction
Talcott
Testimony
Ultra Sound
Links

Dow Corning Audits AMT

Les Schnoll, Dow Corning Inspector and his impressions of the manufacturing practices and procedures at AMT.

Taken from the evidentiary CDs from the released Griffin Bell documents.
 
DCCKKA26494
 
November 26, 1990                Dow Corning Proprietary
 
To:    Ron Dieck          DCW
         Arnold Lawing    DCW
         Frank Lewis        DCW
 
From:    Les Schnoll    193
 
Subject:    AUDIT OF APPLIED MEDICAL TECHNOLOGY, INC.
 
Attached please find the detailed report of the audit which I performed at Applied Medical Technology, Inc. (AMT) on Nobemver 19, 1990.  The audit was performed at the request of Frank Lewis.  While a copy of the report will also be sent to George Picha (again at Frank's request), I wanted to make you aware of several items which I did not want to pass along to Dr. Picha (however, you may do so if you wish.
 
Generally speaking, the facility and the personnel employed at AMT give an overall impression of disorganization.  There is a general lackadaisical attitude and the organization is fortunate that they haven't been "caught withtheir pants down".  Their perception is myopic and they do not perceive that their operations are as weak as they really are; one example of this is the manner in which they completed the "Supplier Quality Audit" checklist which I sent to them prior to the audit.  Their responses and the real life situation (as found during the audit) are generally at opposite ends of the spectrum.
 
According to AMT personnel, an audit by an Inspector of the United States Food and Drug Administration was performed in June of 1990; allegedly, the only item identified on a Form 483 which was left with them was the fact that AMT did not have a contract with their contract sterilizer (Ethox Corporation).  This discrepancy has since been corrected.  Again the Inspector allegedly spent two days in the AMT facilities (incredible, considering the dearth of facilities to audit) and found nothing else.  However, in a perod of four hours, I was able to identify problems of such a qualitative and quantitative nature that would warrant a regulatory letter from the District office of the Agency.  I realize that the typical FDA Inspector is not "rocket scientist", but he or she could not possibly be that bad.  I would recommend that we obtain a copy of the Establishment Inspection Report (EIR) filed for the audit through the Freedom of Information Act.  Either Harvy Steinberg or Bailey Lipscomb can do this for you, if you provide the Food and Drug Administration Information officer with the approximate date of the audit, the facility and location, and the establishment registration number (1526012)
 
While we may elect to continue to have AMT manufacture their current product line of microvascular instruments for Dow Corning Wright (and I would strongly recommend that you make that ongoing relationship contingent on documented corrective actions to the deficiencies identified during the audit), there would have to be an incredible leap of faith to consider AMT capable fo manufacturing implant products for sale by Dow Corning Corporation.
 
I trust that this information (and that which follows in the audit report) will provide you with sufficient detail to make a decision concerning an ongoing relationship with Applied Medical Technology, Inc.  Please do not hesitate to contact me if you require any additional assistance.
 
Les
 
 
 
 
 
 

Site maintained by Pamela G. Dowd